ArticleJournal of orthopaedic case reports2026
Escherichia hermannii: A Rare Pathogen in Implant-Associated Infection Following a Type III C Open Distal Radius Fracture - A Case Report.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Escherichia hermannii is an infrequent monomicrobial pathogen in human infections. Notably, it has never been documented as the sole isolate in cases of infected radial shaft fractures. Case Report: This report presents a case of a non-union in a distal third radius shaft fracture associated with an E. hermannii-infected implant that remained in situ. The patient, who suffered a crush injury 3 months prior, initially underwent open reduction and internal fixation using a fibula strut graft secured with a titanium plate, along with primary wound closure. However, after 12 weeks, he developed an infection at the implant site, accompanied by a sinus tract. To address this complication, a repeat debridement was performed, and a retention strategy was implemented, allowing the original implant to be preserved. Conclusion: The patient was treated with intravenous meropenem for 7 days, followed by an 11-week course of oral ciprofloxacin. At the conclusion of treatment, he remained free of infection, asymptomatic, and was able to continue working with excellent functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.